In a previous communication, we demonstrated that, in the prevention of exit-site
infection (ESI) in children, the
cleansing agent 50%
Amuchina (electrolytic chloroxidizer.
Amuchina SpA, Genoa, Italy) is more effective than 10%
povidone iodine and as effective as 4%
chlorhexidine, but with fewer adverse secondary effects. In the present study, we assessed, in an Argentine pediatric population, whether
Amuchina 3% is as effective as
Amuchina 50% in preventing ESI in children on chronic
peritoneal dialysis. In an open-label, single-center prospective study, 27 children (mean age: 7.2 years; range: 1.7-17 years) used 3%
Amuchina as a
cleansing agent for the daily care of a healthy exit site. Of the 27 children, 14 were switched from 50%
Amuchina to 3%
Amuchina, and 13 were using the 3%
Amuchina for the first time. The control group consisted of 18 patients who had previously used 50%
Amuchina as a
cleansing agent. We followed the recommendations of the International Society for
Peritoneal Dialysis with regard to exit-site care, which include keeping the
cleansing agent out of the sinus and rinsing the exit site with sterile water.
Amuchina was used from the first post-implantation care of the exit site. No adverse secondary effects were seen with the use of
Amuchina at either concentration. Patients using 3%
Amuchina presented an ESI rate similar to that of patients using
Amuchina 50%. The cost of 3%
Amuchina was significantly lower than that of the 50% concentration, and it was even lower than the cost for 10%
povidone iodine or 4%
chlorhexidine. Although more research trials are needed to assess the efficacy of 3%
Amuchina, we conclude that 3%
Amuchina is the best and most cost-effective
cleansing agent for the daily care of a healthy exit site in children on chronic
peritoneal dialysis.